Sonja Nelson's Net Worth
$4.6 Million
Who is Sonja Nelson?
Sonja Nelson has an estimated net worth of $4.6 Million. This is based on reported shares across multiple companies, which include Ambrx Biopharma, Inc., NantKwest, Inc., Motus GI Holdings, Inc., and Ambrx Biopharma Inc..
SEC CIK
Sonja Nelson's CIK is 0001674905
Past Insider Trading and Trends
2023 was Sonja Nelson's most active year for acquiring shares with 5 total transactions. Sonja Nelson's most active month to acquire stocks was the month of December. 2020 was Sonja Nelson's most active year for disposing of shares, totalling 4 transactions. Sonja Nelson's most active month to dispose stocks was the month of December. 2021 saw Sonja Nelson paying a total of $104,665.51 for 102,302 shares, this is the most they've acquired in one year. In 2021 Sonja Nelson cashed out on 89,728 shares for a total of $780,397.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ambrx Biopharma, Inc. (AMAM) Snapshot price: $27.78
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.94K |
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +10.09% | 50K |
—
|
—
| 545.78K |
Dec 11
| |||
Form 4
| -8.94% | -12.78K |
$9.82 | -$125,479.96 | 130.08K |
Oct 27
| |||
| No matching records found | |||||||||
NantKwest, Inc. (IBRX) Snapshot price: $4.195
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.50% | -5.00K |
$9.04 | -$210,572.52 | 15.41K |
Scheduled
|
Jan 12
| ||
Form 4
| -44.77% | -16.54K |
$8.34 | -$465,159.75 | 20.41K |
Scheduled
|
Jan 4
| ||
Form 4
| +21.51% | 6.54K |
$11.18 | -$38,660.44 | 36.95K |
Aug 2
| |||
Form 4
| +41.17% | 8.87K |
$2.82 | -$17,292.24 | 30.41K |
Mar 23
| |||
Form 4
| +43.61% | 6.54K |
$1.27 | -$4,391.66 | 21.54K |
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Motus GI Holdings, Inc. (MOTS) Snapshot price: $0.6335
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +453.07% | 82.5K |
—
|
—
| 100.71K |
Jan 5
| |||
Form 4
|
∞
| 18.21K |
—
|
—
| 18.21K |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ambrx Biopharma Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
∞
| 1M |
—
|
—
| 1M |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||